BRPI0911067B8 - métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido - Google Patents

métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Info

Publication number
BRPI0911067B8
BRPI0911067B8 BRPI0911067A BRPI0911067A BRPI0911067B8 BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8 BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 A BRPI0911067 A BR PI0911067A BR PI0911067 B8 BRPI0911067 B8 BR PI0911067B8
Authority
BR
Brazil
Prior art keywords
methods
analyte
absence
systems
determining
Prior art date
Application number
BRPI0911067A
Other languages
English (en)
Inventor
C Curry Adam
Sandmann Christian
Weidemaier Kristin
Pederson Allphin Lori
Kuroda Melody
A Fulcher Robert
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of BRPI0911067A2 publication Critical patent/BRPI0911067A2/pt
Publication of BRPI0911067B1 publication Critical patent/BRPI0911067B1/pt
Publication of BRPI0911067B8 publication Critical patent/BRPI0911067B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54391—Immunochromatographic test strips based on vertical flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles

Abstract

métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido nanopartículas revestidas compreendendo um núcleo envolvido por um invólucro que aumenta a refletância da nanopartícula, em que a nanopartícula revestida não inclui uma molécula ativa no raman, são fornecidas. dispositivos de teste e métodos de imunoensaio utilizando as nanopartículas revestidas são fornecidos.
BRPI0911067A 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido BRPI0911067B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7103508P 2008-04-09 2008-04-09
US61/071.035 2008-04-09
PCT/US2009/039951 WO2009126735A1 (en) 2008-04-09 2009-04-08 Sensitive immunoassays using coated nanoparticles

Publications (3)

Publication Number Publication Date
BRPI0911067A2 BRPI0911067A2 (pt) 2015-12-29
BRPI0911067B1 BRPI0911067B1 (pt) 2020-10-20
BRPI0911067B8 true BRPI0911067B8 (pt) 2021-07-27

Family

ID=40756968

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911067A BRPI0911067B8 (pt) 2008-04-09 2009-04-08 métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido

Country Status (11)

Country Link
US (2) US20090305231A1 (pt)
EP (2) EP2952897B1 (pt)
JP (3) JP5792614B2 (pt)
CN (2) CN102016585B (pt)
AU (1) AU2009233755B2 (pt)
BR (1) BRPI0911067B8 (pt)
CA (1) CA2721064C (pt)
ES (2) ES2544257T3 (pt)
MX (1) MX2010011176A (pt)
TW (1) TW200946913A (pt)
WO (1) WO2009126735A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090291508A1 (en) * 2008-05-20 2009-11-26 Rapid Pathogen Screening Inc. Nanoparticles in diagnostic tests
US8470608B2 (en) * 2008-05-20 2013-06-25 Rapid Pathogen Screening, Inc Combined visual/fluorescence analyte detection test
US8669052B2 (en) 2008-06-10 2014-03-11 Rapid Pathogen Screening, Inc. Lateral flow nucleic acid detector
US8815609B2 (en) 2008-05-20 2014-08-26 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with diverting zone
US8609433B2 (en) 2009-12-04 2013-12-17 Rapid Pathogen Screening, Inc. Multiplanar lateral flow assay with sample compressor
US9068981B2 (en) 2009-12-04 2015-06-30 Rapid Pathogen Screening, Inc. Lateral flow assays with time delayed components
US20130196310A1 (en) 2008-05-20 2013-08-01 Rapid Pathogen Screening, Inc. Method and Device for Combined Detection of Viral and Bacterial Infections
US8962260B2 (en) 2008-05-20 2015-02-24 Rapid Pathogen Screening, Inc. Method and device for combined detection of viral and bacterial infections
US20110086359A1 (en) 2008-06-10 2011-04-14 Rapid Pathogen Screening, Inc. Lateral flow assays
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) * 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2012051218A2 (en) * 2010-10-11 2012-04-19 Mbio Diagnostics, Inc. Fluidic assay cartridge with controlled passive flow
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
US8591759B2 (en) * 2011-05-31 2013-11-26 Chemgreen Innovation Inc. Magnetic nanocomposite material and processes for the production thereof
US9524372B2 (en) 2011-09-09 2016-12-20 Alverix, Inc. In-vitro diagnostic device using external information in conjunction with test results
US9715579B2 (en) 2011-09-09 2017-07-25 Alverix, Inc. Distributed network of in-vitro diagnostic devices
US10725033B2 (en) * 2012-01-31 2020-07-28 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
US10816492B2 (en) * 2012-01-31 2020-10-27 Regents Of The University Of Minnesota Lateral flow assays with thermal contrast readers
WO2014025037A1 (ja) 2012-08-10 2014-02-13 浜松ホトニクス株式会社 表面増強ラマン散乱素子及びその製造方法
US9863883B2 (en) 2012-08-10 2018-01-09 Hamamatsu Photonics K.K. Surface-enhanced raman scattering element
JP6151948B2 (ja) 2013-03-29 2017-06-21 浜松ホトニクス株式会社 表面増強ラマン散乱ユニット及びラマン分光分析方法
EP2911791A4 (en) 2012-10-29 2016-11-02 Mbio Diagnostics Inc SYSTEM FOR IDENTIFYING BIOLOGICAL PARTICLES, CARTRIDGE AND ASSOCIATED METHODS
EP2811301B1 (en) * 2012-11-15 2017-05-10 Ortho-Clinical Diagnostics, Inc. Quality/process control of a lateral flow assay device based on flow monitoring
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
US10005847B2 (en) 2014-05-27 2018-06-26 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
JP2017518989A (ja) 2014-05-27 2017-07-13 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 抗ｃｄ２０糖操作抗体群およびその使用
JP6894239B2 (ja) 2014-05-27 2021-06-30 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 増強された抗体の有効性のための普遍的グリコフォームに関する組成物および方法
US11332523B2 (en) 2014-05-28 2022-05-17 Academia Sinica Anti-TNF-alpha glycoantibodies and uses thereof
US11205757B2 (en) * 2014-11-06 2021-12-21 Sn Display Co., Ltd. Core-shell structured perovskite particle light-emitter, method of preparing the same and light emitting device using the same
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US10808287B2 (en) 2015-10-23 2020-10-20 Rapid Pathogen Screening, Inc. Methods and devices for accurate diagnosis of infections
WO2017222833A1 (en) 2016-06-22 2017-12-28 Becton, Dickinson And Company Modular assay reader device
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
US10796901B2 (en) * 2016-09-29 2020-10-06 Nanoco Technologies Ltd. Shelling of halide perovskite nanoparticles for the prevention of anion exchange
CN110554018A (zh) * 2018-05-31 2019-12-10 上海市刑事科学技术研究院 检测水溶液中4-溴甲卡西酮的表面增强拉曼材料及其制备方法
CN111686826B (zh) * 2019-03-15 2023-05-23 国家纳米科学中心 分层结构的微流控芯片及其应用
US11376588B2 (en) 2020-06-10 2022-07-05 Checkable Medical Incorporated In vitro diagnostic device
TWI756764B (zh) * 2020-07-31 2022-03-01 國立中興大學 光電流電極及光電免疫感測裝置
EP4298429A1 (en) * 2021-02-24 2024-01-03 Univerzita Palackého v Olomouci Test strip for surface-enhanced raman spectroscopy, method for its preparation and use thereof
US20220317124A1 (en) 2021-04-01 2022-10-06 Becton Dickinson And Company Methods for enhancing specificity and sensitivity of group a streptococcus immunoassay
TWI792554B (zh) * 2021-09-10 2023-02-11 財團法人工業技術研究院 鈣鈦礦前驅物溶液檢測法
WO2023055305A1 (en) * 2021-09-28 2023-04-06 National Science And Technology Development Agency Qualitative dextran detection device and use thereof
CN115792216B (zh) * 2022-11-25 2023-11-03 中国农业科学院北京畜牧兽医研究所 用于检测毒素的侧向层析试纸条、制备方法和使用方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920046A (en) 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
USRE38430E1 (en) * 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
CA1303983C (en) * 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
ES2050704T5 (es) 1987-04-27 2004-04-16 Inverness Medical Switzerland Gmbh Inmunoensayos y dispositivos para su realizacion.
CA1313616C (en) * 1987-06-01 1993-02-16 Robert B. Sargeant Lateral flow, non-bibulous membrane protocols
AU2684488A (en) * 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US6194220B1 (en) * 1996-09-25 2001-02-27 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
US5798273A (en) 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
AU4432297A (en) * 1996-09-25 1998-04-17 Universal Health-Watch, Inc. Diagnostic test devices with improved fluid movement and resistance to interferences
US5998221A (en) 1996-09-25 1999-12-07 Becton, Dickinson And Company Non-instrumented assay with quantitative and qualitative results
EP1062510A2 (en) * 1998-03-10 2000-12-27 Strategic Diagnostics Inc. Integrated assay device and methods of production and use
US6136610A (en) * 1998-11-23 2000-10-24 Praxsys Biosystems, Inc. Method and apparatus for performing a lateral flow assay
WO2000031538A1 (en) * 1998-11-23 2000-06-02 Praxsys Biosystems, Inc. Improved lateral flow assays
WO2001018235A2 (en) * 1999-09-09 2001-03-15 Eichrom Technologies, Inc. Lateral flow device with metal oxide indicator and assay method employing same
DK1226422T3 (da) * 1999-10-06 2008-04-14 Oxonica Inc Overflade-forstærkede spektroskopi-aktive nano-partikler
US7052831B2 (en) 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
ES2321696T3 (es) * 2002-06-07 2009-06-10 Cholestech Corporation Modulo de casete automatizado para un aparato para llevar a cabo inmunoensayos y uso del mismo.
ATE487941T1 (de) * 2003-03-10 2010-11-15 Sekisui Medical Co Ltd Verfahren zur untersuchung von proben und probenbehälter zur verwendung bei dem untersuchungsverfahren
ATE509275T1 (de) * 2003-09-23 2011-05-15 Epinex Diagnostic Inc Schnelltest für glykiertes albumin
US20050148100A1 (en) * 2003-12-30 2005-07-07 Intel Corporation Methods and devices for using Raman-active probe constructs to assay biological samples
JP2006071520A (ja) * 2004-09-03 2006-03-16 Enbiotec Laboratories:Kk Ｐｃｂの簡易検出方法
US7723100B2 (en) * 2006-01-13 2010-05-25 Becton, Dickinson And Company Polymer coated SERS nanotag
ES2601391T3 (es) * 2006-01-27 2017-02-15 Becton Dickinson And Company Inmunoensayo de flujo lateral con modalidad de detección encapsulada

Also Published As

Publication number Publication date
JP6379149B2 (ja) 2018-08-22
CA2721064A1 (en) 2009-10-15
EP2271939B1 (en) 2015-06-17
ES2544257T3 (es) 2015-08-28
BRPI0911067A2 (pt) 2015-12-29
EP2952897A1 (en) 2015-12-09
US20130281310A1 (en) 2013-10-24
JP2015148629A (ja) 2015-08-20
JP2011516889A (ja) 2011-05-26
EP2271939A1 (en) 2011-01-12
CA2721064C (en) 2016-11-01
CN102016585A (zh) 2011-04-13
AU2009233755B2 (en) 2015-11-26
CN102016585B (zh) 2017-10-10
JP2017015732A (ja) 2017-01-19
BRPI0911067B1 (pt) 2020-10-20
JP5792614B2 (ja) 2015-10-14
WO2009126735A1 (en) 2009-10-15
ES2627190T3 (es) 2017-07-27
TW200946913A (en) 2009-11-16
AU2009233755A1 (en) 2009-10-15
MX2010011176A (es) 2011-02-24
CN107561270B (zh) 2019-06-04
EP2952897B1 (en) 2017-03-22
CN107561270A (zh) 2018-01-09
US20090305231A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
BRPI0911067B8 (pt) métodos e sistemas para determinar a presença ou ausência de um analito em uma amostra de líquido
BR112014025384A8 (pt) método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares
BRPI0912751A2 (pt) métodos de análise e avaliação de um objeto com um sistema de laser de ultra som e instrumento para inspecionar um objeto.
BRPI0720707A2 (pt) Sistema de teste para uso com um tampão para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; sistema de teste para testar a presença de moléculas alvo de um ou mais tipos de alvo em uma amostra de teste biológico; e método de focalização de moléculas para facilitar um teste da presença de moléculas alvo de um ou mais tipos de alvo de uma amostra de teste biológico.
WO2009117168A3 (en) Detection of analytes using metal nanoparticle probes and dynamic light scattering
BR112013012501A2 (pt) método e sistema de teste de analito com notificação de tendências de analito altas e baixas
BR112012020251A2 (pt) dispositivo de análise para a aquisição de amostra, tratamento e reação
WO2008039918A3 (en) Methods and apparatus for hybrid outlier detection
BR112012013362A2 (pt) sistema para a determinação de um valor para pelo menos um parâmetro que descreve a atividade microbiana de organismos biológicos individuais em uma amostra de líquido, e, método para a determinação da atividade microbiana em uma amostra de líquido
BR112012029281A2 (pt) anticorpo trop-2 anti-humano tendo atividade anti-tumor in vivo
WO2014060549A3 (en) Statistical linguistic analysis of source content
EP3070478A4 (en) Analyte testing automation system, biological sample check module, and biological sample check method
CR20110241A (es) Método para inducir pluripotencia en células
WO2007114986A3 (en) Cooperative probes and methods of using them
BRPI0912305A2 (pt) analisador químico, método para análise baseada em amostra, dispositivo para manipulação de cuvetas e método de carregamento.
BRPI1014652A2 (pt) sensor eletroquímico amperométrico, método para fabricar o mesmo, sonda amperométrica de medição do teor de uma substância de oxirredução dissolvida em um líquido e uso de um sensor.
BR122019018448B8 (pt) método para extração de succinilacetona e um ou mais analitos biológicos adicionais
DK2129391T3 (da) Diagnostisk fremgangsmåde
WO2008111464A1 (ja) スプライシング異常を指標とする抗ガン剤の作用検定方法
WO2007113838A3 (en) Device, system and method for in-vivo analysis
ECSP11011376A (es) Dispositivo y procedimiento para la verificación y para el análisis cuantitativo de analitos, particularmente de micotoxinas
BR112012010273A2 (pt) composição, dispositivo, método e artigo para detecção de um analito em uma amostra por leitura óptica colorimétrica, e, uso da composição
WO2011137388A3 (en) Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample
BR112014032916A2 (pt) anticorpos anti-fármacos e usos destes para o monitoramento de fármaco
BR112014012003A2 (pt) sistema de controle de qualidade, método e meio legível por computador para o uso com bens de consumo, usuários e dispositivos de teste de diagnóstico biológico/ambiental

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 20/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO